NCL Technology Ventures Ltd. — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Curesponsecuresponse.cominJun 2020 · $6M
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts.
AI & Machine LearningBiotechDigital HealthHealthtech
Guy Neev(Co-Founder & CEO)inDr. Ravid Straussman(Scientific Founder)Dr. Seth Salpeter(Co-Founder & CTO)Eran Dor(CFO)
Co-investorsaMoon
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.